An interventional study of Epidural analgesia and Combined spinal-epidural analgesia in Labor Pain, Pain and Neurologic Manifestations, sponsored by ShanWu Feng, M.D.. Status unknown at 1 site in China. Open to female participants aged 20 Years to 45 Years. Per ClinicalTrials.gov, last updated 2015-01-15.
Sponsored by ShanWu Feng, M.D. · Not applicable, Interventional, and Treatment
Epidural analgesia is associated with maternal intra-partum fever during labor. Intermittent epidural injections appear to reduce the incidence of maternal intra-partum fever compared to continuous epidural infusion during labor analgesia. However, the optimal combination of bolus volume and administrating interval has not yet been compared. The purpose of this prospective, randomized, double-blind trial was to determine how intermittent epidural bolus reduced the incidence of maternal intra-partum fever compared with continuous epidural infusion during labor.
198 studies on the registry are indexed under Neurologic Manifestations; 67 are open to participants now.
This study's planned enrollment of 12,000 is above the median of 40 across 107 interventional studies indexed under Neurologic Manifestations.
Browse Neurologic Manifestations studies →This is the only study on the registry with ShanWu Feng, M.D. as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Epidural analgesia (EA) with continuous epidural infusion(CEI)
Procedure: Epidural analgesia · Procedure: Continuous epidural infusion
Combined spinal-epidural analgesia (CSEA) with continuous epidural infusion(CEI)
Procedure: Combined spinal-epidural analgesia · Procedure: Continuous epidural infusion
Epidural analgesia (EA) with intermittent epidural bolus (IEB, 2.5 mL bolused every 15 minutes)
Procedure: Epidural analgesia · Procedure: Intermittent epidural bolus
Epidural analgesia (EA) with intermittent epidural bolus (IEB, 5ml bolused every 30 minutes)
Procedure: Epidural analgesia · Procedure: Intermittent epidural bolus
Epidural analgesia (EA) with intermittent epidural bolus (IEB, 10ml bolused every 60 minutes)
Procedure: Epidural analgesia · Procedure: Intermittent epidural bolus
Combined spinal-epidural analgesia (CSEA) with intermittent epidural bolus (IEB, 2.5 mL bolused every 15 minutes)
Procedure: Combined spinal-epidural analgesia · Procedure: Intermittent epidural bolus
Combined spinal-epidural analgesia (CSEA) with intermittent epidural bolus (IEB, 5ml bolused every 30 minutes)
Procedure: Combined spinal-epidural analgesia · Procedure: Intermittent epidural bolus
Combined spinal-epidural analgesia (CSEA) with intermittent epidural bolus (IEB, 10ml bolused every 60 minutes)
Procedure: Combined spinal-epidural analgesia · Procedure: Intermittent epidural bolus
Maternal oral and tympanic temperature
Time frame: At time of initiation of analgesia and hourly thereafter until 4 hours postpartum (approximately 12 hours)
Maternal serum Interleukin-1β
Time frame: At time of placental delivery and 3, 6 and 12 hours later
Cord serum Interleukin-1β
Time frame: At time of placental delivery
Maternal serum Interleukin-6
Time frame: At time of placental delivery and 3, 6 and 12 hours later
Cord serum Interleukin-6
Time frame: At time of placental delivery
Maternal serum Interleukin-10
Time frame: At time of placental delivery and 3, 6 and 12 hours later
Cord serum Interleukin-10
Time frame: At time of placental delivery
Maternal serum tumor necrosis factor-α
Time frame: At time of placental delivery and 3, 6 and 12 hours later
Cord serum tumor necrosis factor-α
Time frame: At time of placental delivery
Regression and correlation analyses between maternal and cord serum cytokines
Time frame: At twelve hours postpartum
Placental routine pathologic examination
Time frame: At time of placental delivery
Maternal and cord blood gase analysis
Time frame: At time of placental delivery
Maternal modified Bromage scale and visual analogue scale
Time frame: At time of initiation of analgesia and hourly thereafter until 2 hours postpartum (approximately 10 hours)
Rescue boluses, n of rescue boluses, and the consumption of the ropivacaine/sufentanil mixture
Time frame: At two hours postpartum
Rates of cesarean delivery and instrument-assisted delivery
Time frame: At time of placental delivery
Indications of cesarean delivery
Time frame: Initiation of analgesia to placental delivery (approximately 8 hours)
Duration of analgesia
Time frame: Initiation of analgesia to 2 h postpartum (approximately 10 hours)
Durations of labor stages
Time frame: From the beginning of regular contraction of uterus to the end of the labor (approximately 12 hours)
Maternal satisfaction with analgesia
Time frame: At two hours postpartum
Use of oxytocin after analgesia
Time frame: At twenty-four hours postpartum
Low back pain at 3 months after vaginal delivery
Time frame: At the third month after vaginal delivery
Breastfeeding success at 6 weeks after vaginal delivery
Time frame: At the sixth week after successful delivery
Neonatal Apgar scale
Time frame: At the first and fifth minutes after baby was born
Incidence of maternal side effects
Time frame: Initiation of analgesia to 2 hour postpartum (approximately 10 hours)
Neonatal Neurologic and Adaptive Capacity Score
Time frame: At 30 min, 2 h, and 24 h after baby was born
Maximal oxytocin dose
Time frame: At twenty-four hours postpartum
Neonatal sepsis evaluation
Time frame: At 30 min after baby was born
Neonatal antibiotic treatment
Time frame: One week after baby was born
Maternal heart rate, respiratory rate, and blood pressure
Time frame: At time of initiation of analgesia and hourly thereafter until 4 hours postpartum (approximately 12 hours)
Highest thoracic sensory level to alcohol
Time frame: At three hours after initiation of analgesia
Uterine contraction
Time frame: At time of initiation of analgesia and hourly thereafter until 4 hours postpartum (approximately 12 hours)
Neonatal rectal temperature
Time frame: At delivery, 30 min after delivery, and 1 h after delivery
Fetal heart rate
Time frame: From initiation of analgesia to delivery (approximately 8 hours)
Maternal group B streptococcus (GBS) colonization
Time frame: At time of initiation of analgesia
Number of vaginal examinations, duration from rupture of the membranes to delivery, mode of membranes ruptured
Time frame: From initiation of analgesia to delivery (approximately 8 hours)
Neonatal weight
Time frame: At delivery
Uterine artery, umbilical artery and vein, fetus middle cerebral artery by ultrasound
Time frame: At time of initiation of analgesia and hourly thereafter until delivery (approximately 8 hours)
Maternal serum epinephrine, norepinephrine, insulin, glucagon, corticotropin releasing hormone, adrenocorticotropic hormone, cortisol, blood glucose, oxytocin, prostaglandin E2 and prostaglandin F2 alpha
Time frame: At time of initiation of analgesia and hourly thereafter until 4 hours postpartum (approximately 12 hours)
Maternal postpartum depression
Time frame: At time of delivery and daily thereafter until 1 year postpartum (approximately 1 year)
This study is status unknown, as verified in Jan 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.